[1]
2025. Treatment Persistence of Lacosamide, Perampanel and Brivaracetam: An Extended Real-World Analysis from the COMPARE Italian Cohort. Epidemiology, Biostatistics, and Public Health. (Sep. 2025). DOI:https://doi.org/10.54103/2282-0930/29447.